Trisalus Life Sciences Stock Performance
| TLSI Stock | 6.64 0.22 3.21% |
On a scale of 0 to 100, TriSalus Life holds a performance score of 13. The entity has a beta of 1.57, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, TriSalus Life will likely underperform. Please check TriSalus Life's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether TriSalus Life's existing price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in TriSalus Life Sciences are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, TriSalus Life demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (3.21) | Five Day Return (5.68) | Year To Date Return 33.33 | Ten Year Return (36.88) | All Time Return (36.88) |
1 | TriSalus to present at Canaccord, Piper events, 230 p.m. ET and 310 p.m. ET - Stock Titan | 11/11/2025 |
2 | Rockwell Medical Reports Q3 Loss, Lags Revenue Estimates | 11/12/2025 |
3 | TriSalus Life Sciences, Inc. Q3 2025 Earnings Call Transcript | 11/14/2025 |
4 | FY2026 EPS Estimates for TLSI Increased by Cantor Fitzgerald | 11/19/2025 |
5 | Acquisition by David Patience of 65000 shares of TriSalus Life subject to Rule 16b-3 | 11/24/2025 |
6 | TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025 | 12/04/2025 |
7 | TriSalus revenue jumps 57 percent in third quarter - BizWest | 12/19/2025 |
| Begin Period Cash Flow | 12.1 M | |
| Total Cashflows From Investing Activities | -345 K |
TriSalus Life Relative Risk vs. Return Landscape
If you would invest 456.00 in TriSalus Life Sciences on October 1, 2025 and sell it today you would earn a total of 208.00 from holding TriSalus Life Sciences or generate 45.61% return on investment over 90 days. TriSalus Life Sciences is currently generating 0.6826% in daily expected returns and assumes 4.1622% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than TriSalus, and 87% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
TriSalus Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for TriSalus Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as TriSalus Life Sciences, and traders can use it to determine the average amount a TriSalus Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.164
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TLSI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average TriSalus Life is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TriSalus Life by adding it to a well-diversified portfolio.
TriSalus Life Fundamentals Growth
TriSalus Stock prices reflect investors' perceptions of the future prospects and financial health of TriSalus Life, and TriSalus Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on TriSalus Stock performance.
| Return On Equity | -4.96 | ||||
| Return On Asset | -0.61 | ||||
| Profit Margin | (0.98) % | ||||
| Operating Margin | (0.78) % | ||||
| Current Valuation | 354.69 M | ||||
| Shares Outstanding | 49.96 M | ||||
| Price To Book | 30.29 X | ||||
| Price To Sales | 8.52 X | ||||
| Revenue | 29.43 M | ||||
| Gross Profit | 33.79 M | ||||
| EBITDA | (36.16 M) | ||||
| Net Income | (30.05 M) | ||||
| Total Debt | 23.63 M | ||||
| Book Value Per Share | (0.54) X | ||||
| Cash Flow From Operations | (40.84 M) | ||||
| Earnings Per Share | (2.12) X | ||||
| Market Capitalization | 342.76 M | ||||
| Total Asset | 23.97 M | ||||
| Retained Earnings | (279.55 M) | ||||
| Working Capital | 10.44 M | ||||
About TriSalus Life Performance
By evaluating TriSalus Life's fundamental ratios, stakeholders can gain valuable insights into TriSalus Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if TriSalus Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if TriSalus Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 360.11 | 231.03 | |
| Return On Tangible Assets | (1.39) | (1.46) | |
| Return On Capital Employed | (2.63) | (2.50) | |
| Return On Assets | (1.39) | (1.46) | |
| Return On Equity | 1.28 | 1.35 |
Things to note about TriSalus Life Sciences performance evaluation
Checking the ongoing alerts about TriSalus Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for TriSalus Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| TriSalus Life appears to be risky and price may revert if volatility continues | |
| TriSalus Life has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 29.43 M. Net Loss for the year was (30.05 M) with profit before overhead, payroll, taxes, and interest of 33.79 M. | |
| TriSalus Life generates negative cash flow from operations | |
| TriSalus Life has a frail financial position based on the latest SEC disclosures | |
| About 42.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: TriSalus revenue jumps 57 percent in third quarter - BizWest |
- Analyzing TriSalus Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether TriSalus Life's stock is overvalued or undervalued compared to its peers.
- Examining TriSalus Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating TriSalus Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of TriSalus Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of TriSalus Life's stock. These opinions can provide insight into TriSalus Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for TriSalus Stock analysis
When running TriSalus Life's price analysis, check to measure TriSalus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TriSalus Life is operating at the current time. Most of TriSalus Life's value examination focuses on studying past and present price action to predict the probability of TriSalus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TriSalus Life's price. Additionally, you may evaluate how the addition of TriSalus Life to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |